Geneos Wealth Management’s VirnetX Holding Corp VHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-51
Closed -$1K 2589
2022
Q2
$1K Hold
51
﹤0.01% 2548
2022
Q1
$1K Hold
51
﹤0.01% 2705
2021
Q4
$2K Sell
51
-90
-64% -$6.24K ﹤0.01% 2614
2021
Q3
$11K Hold
141
﹤0.01% 2199
2021
Q2
$11K Hold
141
﹤0.01% 2180
2021
Q1
$13K Hold
141
﹤0.01% 2272
2020
Q4
$15K Hold
141
﹤0.01% 2062
2020
Q3
$13K Hold
141
﹤0.01% 1866
2020
Q2
$17K Buy
141
+6
+4% +$734 ﹤0.01% 1704
2020
Q1
$14K Hold
135
﹤0.01% 1667
2019
Q4
$10K Hold
135
﹤0.01% 1987
2019
Q3
$14K Sell
135
-57
-30% -$6.79K ﹤0.01% 1771
2019
Q2
$23K Hold
192
﹤0.01% 1574
2019
Q1
$24K Sell
192
-250
-57% -$25.9K ﹤0.01% 1493
2018
Q4
$21K Buy
442
+165
+60% +$11.2K ﹤0.01% 1493
2018
Q3
$25K Sell
277
-225
-45% -$15.3K ﹤0.01% 1486
2018
Q2
$34K Buy
502
+397
+378% +$25.8K ﹤0.01% 1230
2018
Q1
$8K Hold
105
﹤0.01% 1739
2017
Q4
$7K Hold
105
﹤0.01% 1753
2017
Q3
$8K Hold
105
﹤0.01% 1653
2017
Q2
$9K Hold
105
﹤0.01% 1583
2017
Q1
$4K Hold
105
﹤0.01% 1761
2016
Q4
$4K Hold
105
﹤0.01% 1711
2016
Q3
$6K Hold
105
﹤0.01% 1530
2016
Q2
$8K Hold
105
﹤0.01% 1410
2016
Q1
$9K Buy
+105
New +$9.71K ﹤0.01% 1360

Other funds holding VHC

Geneos Wealth Management's VHC Position: Q3 2022 in Review

Geneos Wealth Management sold out of VirnetX Holding Corp (VHC) in Q3 2022, closing a stake of 51 shares — an estimated $1K sold.

Geneos Wealth Management first reported a position in VHC in Q1 2016 and held it in 26 quarters. The position peaked at $34K in Q2 2018. 74 funds tracked by Wall St. Rank hold VHC as of Q3 2022.

  • Geneos Wealth Management reported no remaining VirnetX Holding Corp position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 51 VirnetX Holding Corp shares in Q3 2022, an estimated $1K.
  • Geneos Wealth Management first reported a position in VirnetX Holding Corp in Q1 2016 and held it in 26 quarters.
  • Geneos Wealth Management's VirnetX Holding Corp position peaked at $34K in Q2 2018.
  • 74 funds tracked by Wall St. Rank held VirnetX Holding Corp as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.